Analgesic Tablet Franchise in Ahmedabad

Keptos 25 Tablet Supplier in Mumbai

Pain Relief Tablet Distributor in Delhi

Dexketoprofen Tablet Manufacturer in Bangalore

Anti-Inflammatory Tablet Stockist in Hyderabad
Analgesic Tablet Exporter in Chandigarh

Home/Products /dexketoprofen-25mg-tablet

Keptos 25 Tablet

Composition : Dexketoprofen (25mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Keptos 25 Tablet contains Dexketoprofen 25 mg, a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis, thereby reducing pain, inflammation, and swelling. Its rapid onset of action makes it ideal for acute pain management in various clinical conditions.

Clinically, Dexketoprofen is indicated for musculoskeletal pain, joint disorders, dental pain, postoperative pain, and primary dysmenorrhea. The drug provides effective relief from moderate pain and inflammation, enhancing patient comfort and mobility.

The tablet formulation ensures precise dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, orthopedic clinics, dental clinics, and specialty pharmacies. Oral administration supports convenient dosing and patient adherence.

Keptos 25 Tablet also contributes to improved quality of life by rapidly alleviating pain, reducing inflammation, and facilitating quicker functional recovery. Its well-established efficacy and safety profile make it a trusted analgesic and anti-inflammatory option in routine clinical practice.

Read More

About the Product

Keptos 25 Tablet contains Dexketoprofen 25 mg, a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis, thereby reducing pain, inflammation, and swelling. Its rapid onset of action makes it ideal for acute pain management in various clinical conditions.

Clinically, Dexketoprofen is indicated for musculoskeletal pain, joint disorders, dental pain, postoperative pain, and primary dysmenorrhea. The drug provides effective relief from moderate pain and inflammation, enhancing patient comfort and mobility.

The tablet formulation ensures precise dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, orthopedic clinics, dental clinics, and specialty pharmacies. Oral administration supports convenient dosing and patient adherence.

Keptos 25 Tablet also contributes to improved quality of life by rapidly alleviating pain, reducing inflammation, and facilitating quicker functional recovery. Its well-established efficacy and safety profile make it a trusted analgesic and anti-inflammatory option in routine clinical practice.

Common side effects may include nausea, vomiting, stomach upset, heartburn, and dizziness. Rare but serious effects include gastrointestinal bleeding, peptic ulcers, renal impairment, and hypersensitivity reactions.

Keptos 25 Tablet is indicated for the management of acute pain, musculoskeletal pain, dental pain, dysmenorrhea, and other painful inflammatory conditions, as prescribed by a healthcare professional.

Use Keptos 25 Tablet under medical supervision, especially in patients with a history of gastrointestinal disorders, renal impairment, cardiovascular disease, or hypersensitivity to NSAIDs. Take with food or water to minimize gastrointestinal discomfort. Do not exceed the prescribed dose.

Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation